Prot# CV185030: A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation

Project: Research project

Project Details

Effective start/end date9/2/089/2/11


  • PPD Development (CV185-030 // CV185-030)
  • Bristol-Myers Squibb Pharmaceutical Research Institute (CV185-030 // CV185-030)